Homo sapiens

Chapter 106 Target (Additional update)

After Li Qingye arranged these things.

Then he looked at another piece of information that Chen Jianxiong had just reported, which was about China.

After reading the relevant information, Li Qingye immediately ordered: "Feili, strengthen the investigation of various branches and subsidiaries, especially outsiders."

"Yes, boss."

Chen Jianxiong was also a little worried: "Boss, I suspect that all parts of the world have..."

Li Qingye was even more sure about this than he was: "No need to doubt it, it's like finding a cockroach in your home, secretly it must have been everywhere."

"Then should we strengthen our vigilance?" Chen Jianxiong became increasingly worried.

Li Qingye thought for a while, nodded and said, "Okay, let's take this opportunity to let Luzon and Hongsawady seclusion for a period of time."

"I understand." Chen Jianxiong also knew that this was one of the few things they could do now.

As for other matters, even the Homo sapiens company, which has become much more powerful, does not have the ability to interfere in the family affairs of the five gangsters.

Suddenly Li Qingye ordered again: "During the investigation process, you should send some of the target's blood samples as soon as possible. I need to study it and make preparations just in case."

"Yes, I will arrange it right away." Chen Jianxiong has full confidence in Li Qingye's scientific research ability in the biological field. As long as Li Qingye is willing to take action, the Homo sapiens company will at least be helpless to fight back.

Seeing Chen Jianxiong leaving in a hurry, Li Qingye sat on the sofa and fell into deep thought.

This sudden situation affected many of his plans.

Originally, he wanted to take action against Du Jianxin's family in the near future. However, due to the grounding of planes and the increased intensity of immigration inspections, the soldiers who were preparing to carry out the mission would not be able to get through for a while.

Li Qingye was not upset about this, after all, not everything could be smooth sailing.

And it's not like he doesn't have a backup plan, he just needs a few months to adjust.

Bringing his thoughts back to reality, Li Qingye washed his face in the bathroom, then passed through the disinfection area, and then passed through layers of tight gates to his own exclusive laboratory.

The AIDS target drug he previously developed for Domino and others has entered the final stage of testing.

A dozen scum infected with AIDS were currently being held in a special ward by military assistants, who were monitoring the conditions of these experimental subjects at all times.

"How's it going?"

The assistant reported to him on the 15th: "There is no abnormality in the body of the experimental subject. The HIV virus in the body is basically undetectable, but it cannot be ruled out that it is an illusion."

HIV is very cunning. It often escapes from being killed by drugs and then lies dormant. It waits until the effect of the drugs wears off before it continues to cause trouble.

The target drug developed by Li Qingye is different from traditional AIDS treatment drugs, nor is it the RNA technology that has just emerged in recent years.

This is a customized drug that specifically targets a specific gene target, somewhat similar to an advanced version of an RNA vaccine.

The core of its technology is to quickly determine the genetic sequence of the virus, then use genetic recombination technology to create a suicide virus specifically targeted at the virus, and then inject the suicide virus into the patient's body, allowing the suicide virus and the virus in the patient's body to die together.

In fact, this thing is one of the derivative technologies of gene bomb.

Therefore, this target drug will not cause the patient's body to produce antibodies, but it can kill the virus and is a specialized drug.

Because it is an exclusive drug targeting a specific virus, careful genetic testing of the virus in the patient's body is required before this exclusive drug can be produced.

In other words, there is no way that target drugs can be effective against all AIDS. It can only kill specific HIV viruses.

For example, among the 15 experimental subjects in front of us, the HIV in their bodies is called AIDS, but the genes of these AIDS are different, and exclusive target drugs must be customized for each person.

If we follow traditional technology, the production cost of this exclusive target drug is absolutely sky-high.

Fortunately, the technology of Homo sapiens is different from traditional genetic technology.

The technical points for manufacturing exclusive target drugs include the following two aspects:

First, genetic testing technology. In this regard, the biochip and DNA storage currently owned by Homo sapiens Company use gene location determination technology that can detect quickly, and the results can be obtained almost in seconds.

Second, genetic recombination technology, Li Qingye designed a universal virus bomb framework - [TYBD-(X)-JYZD].

This framework is very simple. The general framework consists of six parts: immune deception gene sequence, structural stabilization gene sequence, target chimeric gene sequence, blasting gene sequence, self-replication restriction gene sequence, and timed disintegration gene sequence.

The target chimeric gene sequence is used to quickly insert the viral target gene.

Although in the process of target gene insertion, only a small part of the target genes will be successfully and completely inserted into the framework each time.

But as long as one of them is successful, the successful part can be extracted through rapid genetic testing, and then use hormones and virus culture media to start self-replication until enough target drugs are obtained.

This step usually only takes about 5 to 12 hours.

In fact, a simplified version of this technology is the current RNA vaccine technology.

The advantage of target drugs is that they kill viruses very quickly, with almost 100% killing rate. They do not give the virus time to mutate, nor do they allow the virus to develop drug resistance. They have almost no side effects on the patient's body. .

The disadvantages are also very obvious. The patient's body cannot produce antibodies and there is a risk of secondary infection. It cannot be used in areas without relevant supporting facilities.

This kind of target drug is more suitable for viruses such as AIDS, Ebola, and rabies, but is not suitable for viruses such as smallpox and influenza.

The reason why it is not suitable for smallpox and influenza is not that it cannot be used, but that these viruses have the characteristics of aerosol transmission. The virus is killed in the patient's body, but there may be other sources of infection in the surrounding environment, which can easily cause repeated infections.

Once the infection is repeated, the previous target drug cannot be used for treatment. Instead, the viral gene must be re-detected, and the target drug must be manufactured based on the viral gene sequence.

Although the genetic testing technology of Homo sapiens is very fast and very cheap, costing only a few cents a time, the raw materials for cultivating target drugs also cost only a dozen yuan.

The problem is that repeated tossing like this can easily lead to leaks, and it also requires a lot of manpower, especially precious professional medical manpower.

Therefore, Li Qingye will use two other options for aerosol-borne viruses such as smallpox.

One is a simplified version of target drug technology-RNA vaccine.

The other is bacteriocins (antibiotics) that target universal targets.

In fact, these two technologies are not bad. At least the technology Li Qingye has is more complete than the same type of RNA vaccine technology and antibiotic technology currently used by humans.

The principles of the two are basically the same, but Li Qingye made upgrades and improvements.

For example, RNA vaccine technology, the full name of the technology Li Qingye has is: compound-multi-target combined RNA vaccine technology.

Specifically, more than 10 gene targets are determined for popular virus strains, and then several 10-target RNA vaccines are developed, and then these vaccines are combined and used together.

Faced with this kind of vaccine, even RNA viruses that mutate very quickly are difficult to defeat with two fists.

The same is true for target antibiotics.

This is also the drug that Li Qingye plans to launch on the market through Qingye Group and Homo sapiens company respectively.

As for exclusive target drugs, this technology can only be used internally on a small scale, after all, it involves gene bomb technology.

Thank you for your support (ω`), and thank you to the book friends "Hua Hua, Ru Meng Wei Liang", "Evergreen 1040", and "Book Friends 20200508001617476" for the rewards!

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like